200 related articles for article (PubMed ID: 30352219)
41. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
42. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
[TBL] [Abstract][Full Text] [Related]
43. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K
Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381
[TBL] [Abstract][Full Text] [Related]
44. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
[TBL] [Abstract][Full Text] [Related]
45. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
Adler AS; Littlepage LE; Lin M; Kawahara TL; Wong DJ; Werb Z; Chang HY
Cancer Res; 2008 Jan; 68(2):506-15. PubMed ID: 18199546
[TBL] [Abstract][Full Text] [Related]
46. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
[TBL] [Abstract][Full Text] [Related]
47. The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment.
Zhang QY; Jin R; Zhang X; Sheng JP; Yu F; Tan RX; Pan Y; Huang JJ; Kong LD
Oncotarget; 2016 Oct; 7(43):69688-69702. PubMed ID: 27626169
[TBL] [Abstract][Full Text] [Related]
48. The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway.
Wang Y; Deng X; Xie J; Lu T; Qian R; Guo Z; Zeng X; Liao J; Ding Z; Zhou M; Niu X
Cell Biol Toxicol; 2024 Jun; 40(1):45. PubMed ID: 38864940
[TBL] [Abstract][Full Text] [Related]
49. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
50. Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating miR-506 and suppressing MMP2/16 expression in pancreatic cancer.
Han Y; Ma L; Zhao L; Feng W; Zheng X
Biomed Pharmacother; 2019 Jul; 115():108878. PubMed ID: 31060006
[TBL] [Abstract][Full Text] [Related]
51. Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells.
Schütz AK; Hennes T; Jumpertz S; Fuchs S; Bernhagen J
FEBS Lett; 2012 Jun; 586(11):1645-51. PubMed ID: 22668871
[TBL] [Abstract][Full Text] [Related]
52. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
53. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
[TBL] [Abstract][Full Text] [Related]
54. A Positive Feedback Loop of lncRNA-
Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
[No Abstract] [Full Text] [Related]
55. Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.
Lee YH; Judge AD; Seo D; Kitade M; Gómez-Quiroz LE; Ishikawa T; Andersen JB; Kim BK; Marquardt JU; Raggi C; Avital I; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS
Oncogene; 2011 Oct; 30(40):4175-84. PubMed ID: 21499307
[TBL] [Abstract][Full Text] [Related]
56. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
57. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
Zhao L; Liu L; Dong Z; Xiong J
Oncol Rep; 2017 Dec; 38(6):3522-3530. PubMed ID: 29130108
[TBL] [Abstract][Full Text] [Related]
58. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.
Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X
Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901
[TBL] [Abstract][Full Text] [Related]
59. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
60. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]